Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis - 13/12/14
Doi : 10.1016/j.jaad.2014.09.050
Eric Sorenson, AB a, ⁎ 
, Ethan Levin, MD b, John Koo, MD b, Timothy G. Berger, MD c
, Ethan Levin, MD b, John Koo, MD b, Timothy G. Berger, MD c a Keck School of Medicine, University of Southern California, Los Angeles
b Psoriasis Treatment Center, University of California San Francisco
c Department of Dermatology, University of California San Francisco
∗Correspondence to: Eric Sorenson, AB, 515 Spruce Street, San Francisco, CA 94118
| Authors Sorenson and Levin contributed equally to the production of this manuscript. |
|
| Funding sources: None. |
|
| Conflicts of interest: Dr Koo is a speaker for AbbVie and LEO, and an investigator for Amgen, Janssen, Novartis, Photomedex, Galderma, Pfizer, and Merck. Dr Berger is a consultant for Hyperion Therapeutics and Prescription Solutions. Mr Sorenson and Dr Levin have no conflicts of interest to declare. |
© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 72 - N° 1
P. e40-e42 - janvier 2015 Retour au numéro
Article précédent
- Acral localized acquired cutis laxa: Report of a case associated with inflammatory arthritis
- Tess Peters, Cheryl Barnabe, Wedad Hanna, Duane Barber, Richard M. Haber
- PsAPASH: A new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition
- Rosita Saraceno, Graziella Babino, Andrea Chiricozzi, Arianna Zangrilli, Sergio Chimenti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?